ChampionX Corporation

    ChampionX Corporation

    NNASDAQ:CHX
    25.81
    USD
    0.00
    (0.00%)
    19.32P/E
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    13.83
    9.65
    12.98
    15.75
    14.61
    12.81
    15.25
    18.87
    19.17
    19.07
    18.76
    Basic EPS, GAAP
    0.66
    -0.16
    1.41
    1.2
    0.67
    -5.01
    0.56
    0.77
    1.6
    1.68
    1.54
    Free Cash Flow per Basic Share
    2.23
    1.66
    0.63
    2.12
    2.01
    2.09
    1.63
    2.05
    2.76
    3.09
    2.53
    Dividend per Share
    - -
    1.08
    0.4
    9.52
    - -
    - -
    - -
    0.23
    0.33
    0.37
    0.38
    Book Value per Share
    - -
    - -
    - -
    0.72
    1.39
    -4.29
    -2.6
    -2.61
    -2.31
    -1.24
    -0.89
    Tangible Book Value per Share
    - -
    3.37
    5.03
    -2.75
    -1.47
    3.05
    3.22
    3.43
    3.82
    4.48
    5.44
    Basic Weighted Avg Shares
    78
    78
    78
    77
    77
    148
    202
    202
    196
    191
    191
    Sales/Revenue/Turnover
    1,077
    751
    1,010
    1,218
    1,131
    1,900
    3,075
    3,806
    3,758
    3,634
    3,576
    Operating Margin (%)
    8.26
    -1.21
    9.76
    12.56
    9.09
    -2.87
    5.62
    8.05
    13.48
    12.88
    12.74
    Depreciation Expense
    120
    112
    113
    124
    120
    214
    237
    242
    236
    246
    246
    Net Income, GAAP
    52
    -13
    110
    93
    52
    -744
    113
    155
    314
    320
    293
    Effective Tax Rate (%)
    31.23
    - -
    - -
    23.21
    10.52
    - -
    25.18
    20.45
    24.8
    26.14
    25.65
    Profit Margin (%)
    4.8
    -1.7
    10.85
    7.61
    4.61
    -39.15
    3.68
    4.07
    8.36
    8.81
    8.2
    Working Capital
    - -
    244
    291
    317
    294
    643
    659
    640
    643
    778
    984
    LT Debt
    - -
    2
    6
    663
    575
    989
    771
    681
    636
    673
    633
    Total Equity
    - -
    1,551
    1,640
    976
    1,036
    1,613
    1,754
    1,677
    1,661
    1,831
    1,905
    Return on Invested Capital (%)
    - -
    - -
    - -
    7.16
    5.66
    - -
    4.94
    9.81
    16.18
    14.28
    13.71
    Return on Capital (%)
    - -
    - -
    - -
    30.79
    12.2
    - -
    43.54
    80.83
    189.66
    110.87
    84.46
    Return on Common Equity (%)
    - -
    - -
    - -
    333.24
    63.82
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    27
    23
    22
    LT Borrowings
    592
    591
    591
    LT Finance Leases
    83
    81
    42
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    191
    191
    191
    Market Capitalization
    5,729
    5,165
    5,663

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    1,438
    1,564
    1,769
    Cash, Cash Equivalents & STI
    389
    508
    527
    Accounts Receivable, Net
    434
    467
    418
    Inventories
    547
    497
    497
    Total Current Liabilities
    740
    786
    785
    Payables & Accruals
    621
    649
    637
    ST Debt
    27
    23
    22
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    13.86%
    10.24%
    Free Cash Flow
    - -
    34.1%
    9.15%
    Net Income, GAAP
    - -
    -299.98%
    1.92%
    Sales/Revenue/Turnover
    - -
    29.8%
    -3.31%
    Total Cash Common Dividend
    - -
    - -
    8.54%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    948
    927
    940
    944
    3,758
    2024
    922
    893
    907
    912
    3,634
    2025
    864
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.32
    0.49
    0.4
    0.4
    1.6
    2024
    0.59
    0.28
    0.38
    0.43
    1.68
    2025
    0.45
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.08
    0.08
    0.09
    0.09
    0.33
    2024
    0.09
    0.09
    0.09
    0.09
    0.37
    2025
    0.09
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ChampionX Corporation of Class Action Lawsuit and Upcoming Deadlines - CHX

    • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ChampionX Corporation of Class Action Lawsuit and Upcoming Deadlines – CHX

    • Portnoy Law Firm Announces Class Action on Behalf of ChampionX Corporation Investors

    • CHX FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages ChampionX Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important July 14 Deadline in Securities Class Action - CHX

    • CHAMPIONX DEADLINE TOMORROW JULY 14th: Bragar Eagel & Squire, P.C. Reminds ChampionX Corporation Investors to Contact the Firm Regarding Lead Plaintiff Role Before July 14th

    • CHX DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages ChampionX Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important July 14 Deadline in Securities Class Action - CHX

    • Bronstein, Gewirtz & Grossman LLC Urges ChampionX Corporation Investors to Act: Class Action Filed Alleging Investor Harm

    • DEADLINE TOMORROW: Berger Montague Advises ChampionX Corporation (CHX) Investors to Contact the Firm Before July 14, 2026

    • Bronstein, Gewirtz & Grossman LLC Urges ChampionX Corporation Investors to Act: Class Action Filed Alleging Investor Harm

    • SHAREHOLDER REMINDER: Berger Montague Reminds ChampionX Corporation (CHX) Investors of the July 14, 2026 Deadline

    • Bronstein, Gewirtz & Grossman LLC Urges ChampionX Corporation Investors to Act: Class Action Filed Alleging Investor Harm

    • CHAMPIONX CORPORATION (CHX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ChampionX Corporation Investors of Upcoming Deadline

    • CHX DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ChampionX Corporation Investors to Secure Counsel Before Important July 14 Deadline in Securities Class Action - CHX

    • CHX Lead Plaintiff Deadline Approaching: Robbins LLP Urges Stockholders to Contact the Firm for Information in Advance of the July 14, 2026 Deadline

    • CHX Lead Plaintiff Deadline Approaching: Robbins LLP Urges Stockholders to Contact the Firm for Information in Advance of the July 14, 2026 Deadline

    • Bronstein, Gewirtz & Grossman LLC Urges ChampionX Corporation Investors to Act: Class Action Filed Alleging Investor Harm

    • CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises ChampionX Corporation (CHX) Investors to Inquire About a Securities Fraud Class Action by July 14, 2026

    • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ChampionX Corporation of Class Action Lawsuit and Upcoming Deadlines – CHX

    • CHX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages ChampionX Corporation Investors to Secure Counsel Before Important July 14 Deadline in Securities Class Action - CHX

    • CHX FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ChampionX Corporation Investors to Secure Counsel Before Important July 14 Deadline in Securities Class Action - CHX